Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
Switching to TAF from TDF, each with RPV and FTC
Switching to TAF from TDF, each with RPV and FTC
by julia
Study GS-366-1216. Switch from TDF to TAF, each wi...
Switch from TDF to TAF
Switch from TDF to TAF
by easyho
GS-US-292-0109 Study. GS-US-311-1089 Study. . De...
Switch de TDF a TAF Estudio GS-US-292-0109
Switch de TDF a TAF Estudio GS-US-292-0109
by calandra-battersby
Estudio GS-US-311-1089 . Estudio GS-US-366-1216 ....
HIV Update Ardis Moe, M.D.
HIV Update Ardis Moe, M.D.
by nonhurmer
amoe@mednet.ucla.edu. UCLA CARE clinic/NEVHC Van N...
Use of HCV DAAs with HIV Regimens
Use of HCV DAAs with HIV Regimens
by robaut
Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....
HIV Medicine From Guidelines to Practice
HIV Medicine From Guidelines to Practice
by jubilantbikers
Kiat. . Ruxrungtham. Professor of Medicine, . Chu...
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH
by kittie-lecroy
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infect...
Treating HIV Infection: HIV/AIDS Treatment
Treating HIV Infection: HIV/AIDS Treatment
by celsa-spraggs
A Dynamic Field. SINGLE Study. Phase 3, Open-Labe...
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
by calandra-battersby
Massachusetts General Hospital. Boston, Massachus...
HIV Medicine From Guidelines to Practice
HIV Medicine From Guidelines to Practice
by cheryl-pisano
Kiat. . Ruxrungtham. Professor of Medicine, . Ch...
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
Overview of HIV Epidemiology and Prevention Sciences for ke
Overview of HIV Epidemiology and Prevention Sciences for ke
by alida-meadow
Stefan Baral, MD MPH FRCPC. Center for Public Hea...
NRTI-sparing SPARTAN PROGRESS
NRTI-sparing SPARTAN PROGRESS
by shepard237
RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...
Optimization of Antiretroviral Therapy
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Cabotegravir, Long-acting Injectable
Cabotegravir, Long-acting Injectable
by jacey
Last Updated: October 6, 2023. Prepared by:. David...
Eric S. Daar , MD Michael S.
Eric S. Daar , MD Michael S.
by ButterflyHeart
Saag. , MD. Antiretroviral Therapy:. A Case-Based ...
Brad Hare Nothing to Disclose
Brad Hare Nothing to Disclose
by beatrice
Kaiser Permanente San Francisco Medical Center. Sa...
CROI Update: Best of Boston
CROI Update: Best of Boston
by triclin
p. resented by. NCATEC. March . 18, . 2014. David ...
How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN
How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN
by tawny-fly
Sinead Delany-Moretlwe. Wits RHI, University of t...
Eric S. Daar , MD Professor of Medicine
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Use the Web Browser on Your Mobile Device to Participate in Polling*
Use the Web Browser on Your Mobile Device to Participate in Polling*
by phoebe-click
Go to: pollev.com/CCO2. or scan the QR code below...
What’s Next – and When:
What’s Next – and When:
by sherrill-nordquist
An Update on Injectable . P. revention. Alex R Ri...
ART Initiation: PrEP and
ART Initiation: PrEP and
by alida-meadow
Treatment-naïve Patients . Clinical Instructor, ...
Clinical Management Module
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
The Evidence – PrEP Effectiveness
The Evidence – PrEP Effectiveness
by lindy-dunigan
Module . 1(b). The Evidence in Detail. Session Ov...
Michael S. Saag , MD Eric S.
Michael S. Saag , MD Eric S.
by pamella-moone
Daar. , MD. Antiretroviral Therapy:. A Case-Based...
Eric S. Daar , MD Professor of Medicine
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by cheryl-pisano
FLAMINGO. GS-236-0103. ACTG A5257. WAVES . ARIA ....
The Evidence
The Evidence
by danika-pritchard
– . PrEP. Effectiveness. Module . 1(b). The Ev...
Switch
Switch
by lindy-dunigan
from. TDF to TAF. GS-US-292-0109 Study. GS-US-31...
The Bangkok Tenofovir Study
The Bangkok Tenofovir Study
by marina-yarberry
An HIV pre-exposure prophylaxis trial in Thailand...
ART as prevention: PEP &
ART as prevention: PEP &
by phoebe-click
PrEP. Dr. Laura Waters. HIV/GU Medicine. Brighto...
Cases from the Clinic(ians): Case-based Panel Discussion
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
Switching from TDF/FTC to TAF/
Switching from TDF/FTC to TAF/
by fanny
FTC. Study 311-1089. Switching from TDF/FTC to TAF...
HIV 2020: Time for change
HIV 2020: Time for change
by garcia
Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...
Jeanne Marrazzo, MD, MPH
Jeanne Marrazzo, MD, MPH
by rose
Professor of Medicine. University of Washington. S...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...